Uli Bialucha

Chief Tech/Sci/R&D Officer at XILIO THERAPEUTICS, INC.

Consumer Services

Health Technology

Profile

Uli Bialucha is currently Chief Scientific Officer at Xilio Therapeutics, Inc. since 2022.
Formerly, Dr. Bialucha was Vice President-Drug Discovery at Immunitas Therapeutics, Inc. from 2019 to 2021.
Education includes an undergraduate degree from the University of Sussex and a doctorate from University College London.

Uli Bialucha active positions

Companies	Position	Start
XILIO THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2021-03-31

All active positions of Uli Bialucha

Former positions of Uli Bialucha

Companies	Position	End
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Corporate Officer/Principal	2021-03-31

See the detail of Uli Bialucha's experience

Training of Uli Bialucha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Uli Bialucha's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Sussex University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Health Technology